Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02681341 · ClinicalTrials.gov registry record
Vascular Post Market Review
A clinical trial, sponsored by Baylor Research Institute.
- Completed
- Registry status
- 10
- Enrollment target
NCT02681341: Completed study, sponsored by Baylor Research Institute.
NCT02681341 is a clinical trial that has completed, run by Baylor Research Institute. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02681341 has completed, sponsored by Baylor Research Institute.
- COMPLETED
- Registry status
- 10 participants
- Enrollment target
Study Summary
The primary objective of this study is to confirm that properties of CardioCel provide operative benefit to surgeons when compared to Dacron, CorMatrix, and all other bovine pericardium not treated with proprietary ADAPT engineering.
Primary Outcome
The 6 month duplex US report will measure peak velocity and flow through the repaired carotid artery, caliber, and occlusion/lesion status as per normal parameters used in post-CEA scans.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2016-02 |
| Est. Completion | 2017-09-21 |
What the finished NCT02681341 record still lists
NCT02681341 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 10 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02681341 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02681341 about?
NCT02681341 is a clinical study titled "Vascular Post Market Review". The primary objective of this study is to confirm that properties of CardioCel provide operative benefit to surgeons when compared to Dacron, CorMatrix, and all other bovine pericardium not treated with proprietary ADAPT engineering.
What is the current status of trial NCT02681341?
This trial is currently completed. The enrollment target is 10 participants. The study started on 2016-02. Estimated completion is 2017-09-21.
Who is sponsoring clinical trial NCT02681341?
This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia